MedTrace Logo

USG PECS vs LIA for Breast Cancer Surgery

NCT03555227 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2018-11-29

No results posted yet for this study

Summary

Breast cancer is the most common cancer for which women in the UK (United Kingdom) undergo surgery. A novel ultrasound guided regional anaesthetic technique called the 'Pecs 2' block has recently been described. This study compares ultrasound guided (USG) Pecs 2 block with local anaesthetic infiltration (LIA) for pain relief following breast cancer surgery.

Conditions

  • Breast Cancer Female

Interventions

PROCEDURE

USG PECS2 with Drug A (active)

Ultrasound guided Pecs 2 blocks with 0.25% levobupivacaine

PROCEDURE

USG PECS2 with Drug P (placebo)

Ultrasound guided Pecs 2 blocks with placebo (0.9% saline)

PROCEDURE

Wound infiltration with Drug P (placebo)

Wound infiltration at the end of surgery with Drug P (0.9% saline)

PROCEDURE

Wound infiltration with Drug A (active)

Wound infiltration at the end of surgery with 0.25% levobupivacaine

Sponsors & Collaborators

  • Southern Health and Social Care Trust

    collaborator OTHER_GOV

  • National Health Service, United Kingdom

    lead OTHER_GOV

Principal Investigators

  • Shiva K Arava, MD,FRCA,EDRA · Craigavon Area Hospital, SHSCT

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-25
Primary Completion
2018-11-25
Completion
2018-11-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03555227 on ClinicalTrials.gov